Published price vs quote-only
Shed vs Gala: Which One Publishes Its Price? (2026)
Shed or Gala? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.9 and 7.7 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Put Shed and Gala side by side and the marketing reads almost identically. The programs underneath do not.
Gala publishes what it charges — From $249/mo, as low as $179/mo on longer plans. Shed does not: Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. That asymmetry is the comparison, because you can only price-check one of these two before handing over a medical history.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Gaps in a provider's disclosure are reported as gaps, because they are part of what you are buying.
The short answer
- Easier to price in advance
- Gala — From $249/mo, as low as $179/mo on longer plans. The other side quotes after intake, so a like-for-like total is not available before you apply.
- FDA-approved medication
- Shed — The only side that can write an approved brand-name product at all — it offers name-brand FDA-approved GLP-1 and compounded GLP-1.
- Fastest route to a first shipment
- Shed — 2-minute approval assessment, then home delivery after clinician review.
- Easiest to pay for
- Shed — Neither publishes financing; both expect the full amount monthly.
Side-by-side comparison
The rows below are the ones that differ enough between these two to be worth your attention.
| Shed | Gala | |
|---|---|---|
| Advertised price | 10% off the first month, price quoted after intake | From $249/mo, as low as $179/mo on longer plans |
| Rate after promotions | not published before intake | $249/mo |
| Pricing structure | Quoted only after intake | Cheaper per month the longer you commit |
| Medication | Name-brand FDA-approved GLP-1 and compounded GLP-1 | Compounded semaglutide and compounded tirzepatide |
| Price transparency | Quote only, after intake | Published upfront |
| Membership fee | Not stated | None |
| How fast you start | 2-minute approval assessment | Fully online, no in-office visits |
| State coverage | Not published | Not published |
| Tirzepatide | Not published | Not published |
| Patient reviews | 8,500 | 2,870 |
| eRxDoctor score | 9.9/10 | 7.7/10 |
What Shed and Gala actually cost over a year
Comparing entry prices across these two would be actively misleading, because they escalate differently. Below, both are carried out to six and twelve months so the comparison holds at the point it matters.
| Shed | Gala | |
|---|---|---|
| First month | Not published | $249 |
| Months 2 onward | Not published | $249/mo |
| 6-month total | Not computable | $1,494 |
| 12-month total | Not computable | $2,988 |
| Best published plan | No multi-month discount published | longer-term plan at $179/mo — $2,148/yr |
A like-for-like annual total is not available for Shed: Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. Treat any comparison that quotes one as an estimate someone else has made for you.
Pricing you can check, and pricing you cannot
Gala states its terms upfront: From $249/mo, as low as $179/mo on longer plans, cheaper per month the longer you commit. You can decide whether it fits your budget without giving anyone a medical history.
Shed withholds the figure until 2-minute approval assessment is complete — Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. Whatever the reason, it moves the price conversation to after your commitment rather than before it.
The workaround is straightforward: complete Shed's assessment, get the quote, and then price it against Gala's published $249/mo before agreeing to anything.
A closer look at Shed
Shed offers both name-brand and compounded GLP-1 weight loss medications with integrated coaching, a 2-minute approval assessment, and 10% off your first month. What it is really selling here is one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it.
Getting started means 2-minute approval assessment, after which home delivery after clinician review. Pricing runs on a quoted only after intake basis, quote only, after intake.
On the clinical side, continuous coaching built into every treatment plan, prescribing name-brand FDA-approved GLP-1 and compounded GLP-1.
Shed pros
- Flexibility to choose medication type based on budget and needs
- Offers both FDA-approved name-brand GLP-1 and compounded options on one platform
- Continuous coaching is integrated into treatment, not just a prescription
- Fast 2-minute approval assessment
Shed cons
- Coaching-bundled model can cost more than bare-prescription platforms
- Standard pricing is not published, you receive a personalized quote after intake
- Name-brand options carry significantly higher costs than compounded alternatives
The reservation worth holding, particularly next to Gala: you cannot know what you will pay until you have finished the intake.
Inside the Gala program
Gala GLP-1 is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide with provider check-ins and home delivery. In this pairing, its distinguishing feature is a direct-pay model with dose monitoring included rather than sold as an add-on.
Intake is fully online, no in-office visits. Fulfillment is home delivery. The commercial terms are cheaper per month the longer you commit, published upfront.
Behind the prescription sits provider check-ins and dose monitoring included. Available medication: compounded semaglutide and compounded tirzepatide.
Gala pros
- Provider check-ins and dose monitoring included
- Direct-pay model, no insurance or prior authorizations needed
- Fully online, no in-office visits required
Gala cons
- Higher entry price than several compounded competitors
- Lower long-term pricing requires a multi-month commitment
Read next to Shed, the weak point: the entry price sits above most compounded competitors unless you commit to a longer term.
Who should choose Shed, and who should choose Gala
Choose Shed if:
- you want an FDA-approved finished medication rather than a compounded preparation
- you want continuous coaching built into every treatment plan rather than a prescription alone
- what it leads on is worth paying for in your case: one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it
- the level of clinical contact suits you: continuous coaching built into every treatment plan
Choose Gala if:
- the level of clinical contact suits you: provider check-ins and dose monitoring included
- you would get real value from a direct-pay model with dose monitoring included rather than sold as an add-on
- you are willing to commit for a term in exchange for a lower effective rate (longer-term plan at $179/mo)
- you want the full price in front of you before completing an intake
What each one gives up
On price. Only Gala publishes a rate you can plan against (From $249/mo, as low as $179/mo on longer plans). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On commitment. Gala rewards a longer commitment (longer-term plan at $179/mo), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. Shed provides continuous coaching built into every treatment plan. Gala provides provider check-ins and dose monitoring included. Both are asynchronous-first services and neither replaces a physician who can examine you.
On medication. Shed covers name-brand FDA-approved GLP-1 and compounded GLP-1; Gala covers compounded semaglutide and compounded tirzepatide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
The medication, not the platform
It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.
The FDA publishes an ongoing record of semaglutide products marketed for diabetes and weight loss, and which of them it has actually approved, per FDA.
Dosing errors are the failure mode the FDA has flagged most often with unapproved GLP-1 products, particularly where a patient draws the dose themselves, per FDA.
Take the clinical questions to the prescribing clinician at whichever platform you choose; take the pricing questions to their support team before you pay.
Shed vs Gala: common questions
How much does Shed cost?
Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. That is the honest answer, and it is the main practical drawback next to Gala, which publishes From $249/mo, as low as $179/mo on longer plans upfront. If you go through the intake, ask for the month-two and maintenance-dose prices in writing before paying for the first month.
Is coaching included with Shed or Gala?
Shed includes continuous coaching built into every treatment plan in the monthly price. Gala provides provider check-ins and dose monitoring included, without a separate coaching program. If medication alone has failed you before, the bundled version is the one to price properly rather than the one to cut.
Do Shed or Gala take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Which has more patient reviews, Shed or Gala?
Shed, with 8,500 against 2,870. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
How fast can I start with Shed compared with Gala?
Shed advertises 2-minute approval assessment, with home delivery after clinician review. Gala advertises fully online, no in-office visits, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Shed leads on one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it; Gala leads on a direct-pay model with dose monitoring included rather than sold as an add-on.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- Shed vs MaximusPublished price vs quote-only
- Shed vs He & She MDPublished price vs quote-only
- Gala vs EmbodyBudget vs premium
- Gala vs WellorithmPublished price vs quote-only
- Yucca Health vs WellorithmPublished price vs quote-only
- Yucca Health vs DirectmedsPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Shed or Gala, and does not sell treatment. Read our ranking methodology.